Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine plus sufentanil for postoperative analgesia and cognitive function in elderly patients after gastrointestinal surgery
ChiCTR2300072374Phase 4Completed
- Sponsor
- Tai'an City Central Hospital
- Start
- Oct 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esketamine and sufentanil in postoperative pain and post-operative cognitive decline (POCD) (2 arms), sponsored by Tai'an City Central Hospital. Primary endpoint: Pain score (NRS score). Started Oct 2021; status: completed.
02
Drugs
esketaminesufentanil
03
Conditions
postoperative painpost-operative cognitive decline (POCD)
Beyond the preview
Go deeper on ChiCTR2300072374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072374.